MEDGENERA
  • Sections
    • NEWLY PUBLISHED
    • News from Asia-pacific
    • News from Europe
    • News from USA
    • MEDGENERA ORIGINAL
    • ASSESSMENT
    • MARKET INSIGHTS
    • DRUG TRIAL
    • PROGRESSIVE REVIEW
    • APPS & IMPLANTS
  • About us
  • Plans
  • Education
  • Get Online Training
  • Login
  • Webinar
0
  • Login
  • Get 1-Free month
  • Online Course
  • About us
  • BIORISE
  • Plans
  • BUSINESS
  • CAREER
  • HEALTHCARE & MEDICINE
  • IN-DEPTH STORIES
  • KNOWLEDGE CENTRE
  • MEDGENERA EXCLUSIVE
  • NEWLY PUBLISHED
  • News from Asia-pacific
  • News from Europe
  • News from USA
  • RESOURCE CENTRES
  • TECHNOLOGY

Category: IN-DEPTH STORIES

Proportion
Tiash SahaJanuary 18, 2020

Top Companies Leading the Rare Disease Drug Discovery

KEY POINTS Here are the six companies playing on the front foot in the segment of rare diseases drug discovery. ...

Proportion
Pankaj MishraJanuary 18, 2020

Liquid Biopsy: An Industrial Review

KEY POINTS The liquid biopsy market is forecasted to grow at a CAGR of 20.6 percent to reach over $3 ...

Proportion
Tiash SahaJuly 23, 2018

World’s 10 Top-Selling Orphan Drugs 2018

KEY POINTS Here are the 10 top-selling orphan drugs in terms of their worldwide sales in the previous financial year. ...

Proportion
Pankaj MishraJune 20, 2018

Biosimilars: The Evolution of a New Industry (Review)

KEY POINTS The global oncology mAb market is expected to reach around $45 billion by the end of this decade. ...

Proportion
Tiash SahaJune 13, 2018

10 Potential Drugs in Development for Alzheimer’s Disease (2018)

KEY POINTS Here are the potential Alzheimer’s disease drug candidates in the late stage of clinical development in 2018. Companies ...

Proportion
Tiash SahaApril 2, 2018

Migraine Treatment: The Current Status and New Effective Medicines in Trials (2018)

KEY POINTS Breakthrough discovery of the role of Calcitonin Gene-Related Peptide (CGRP) in the development of a migraine has created ...

Proportion
Pankaj MishraFebruary 13, 2018

The Front Runners Drug Companies in Tackling ‘Superbugs’

KEY POINTS First independent assessment of the global work has been performed to tackle Antimicrobial Resistance (AMR) worldwide. GlaxoSmithKline and ...

Proportion
Pankaj MishraFebruary 8, 2018

NASH Disease: The Story of Industrial Ignorance and Attention

Highlights A comprehensive review of the past and current status of the Non-Alcoholic Steatohepatitis (NASH) drug discovery pipeline. Once thought to be ...

Privacy Policy Terms Payment Policy Education Contact Us About us